Immunostaining Protocol: P-Stat3 (Xenograft and Mice).

Area of Science:

• Oncology
• Cancer Biology
• Molecular Signaling

Background:

• Colorectal cancer (CRC) metastasis is a complex process.
• The tumor microenvironment, including stromal transforming growth factor-beta (TGF-beta), significantly influences cancer progression.
• Understanding the molecular mechanisms driving CRC metastasis is crucial for developing effective therapies.

Purpose of the Study:

• To elucidate the mechanisms by which stromal TGF-beta signaling promotes colorectal cancer cell metastasis.
• To investigate the role of signal transducer and activator of transcription 3 (STAT3) in TGF-beta-induced CRC metastasis.
• To identify key molecular players involved in this process.

Main Methods:

• Utilized mouse models with subcutaneous tumors and metastases.
• Analyzed the activation status of STAT3 (p-STAT3) in CRC cells within a TGF-beta-activated microenvironment.
• Employed GP130 shRNA-mediated knockdown in CRC cells to assess the dependency of STAT3 signaling.

Main Results:

• TGF-beta-activated microenvironments led to prominent accumulation of p-STAT3 in CRC cells within tumors and metastases.
• STAT3 signaling in CRC cells was dependent on GP130, as evidenced by reduced epithelial p-STAT3 levels after GP130 knockdown.
• These findings highlight a critical role for GP130-mediated STAT3 activation in TGF-beta-driven CRC metastasis.

Conclusions:

• Stromal TGF-beta signaling potentiates colorectal cancer metastasis through the activation of STAT3.
• GP130 is essential for mediating STAT3 activation in CRC cells within a TGF-beta-rich microenvironment.
• Targeting the TGF-beta/GP130/STAT3 axis may represent a therapeutic strategy to inhibit CRC metastasis.